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ABSTRACT 
Objective: Isoorientin (ISO) is a flavonoid compound extracted from plant species. The goal of this study 
was to determine the potential antiproliferative effects of ISO in HT-29 human colorectal adenocarcinoma 
cell line in vitro, specifically on cell viability, apoptosis, and cell cycle pathways.
Materials and Methods: The cytotoxic effect of ISO isolated from E. spectabilis was measured using 2,3-bis(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay in HT-29 cell lines. Total RNA 
was isolated using Tri-Reagent protocol. The effects of ISO on apoptosis-related gene were detected using 
real-time polymerase chain reaction (RT-PCR). The findings were analyzed using “Delta-Delta CT” ∆∆CT 
method and evaluated using a computer program. Volcano plot analysis was used for comparing groups and 
the data obtained were statistically analyzed using Student t test.
Results: According to XTT result analysis, the 50% inhibitory concentration (IC50) value of ISO was 125 
µM at the 48th h in HT-29 cells. The RT-PCR analysis in HT-29 cells showed that Cyclin D1 (CCND1 ), 
Cyclin-dependent kinase 6 (CDK6), BAX, BCL-2, Checkpoint kinase 1-2 (CHEK1, CHEK2) and Excision repair 
cross-complementing 1 (ERCC1) expressions were reduced in ISO-treated cells compared with those in the 
control group of cells. P53, P21, Caspase-3 (CASP-3), Caspase-8 (CASP-8), and Caspase-9 (CASP-9)  gene 
expressions were increased Ataxia Telengiectasia and Rad-3 related (ATR) was activated in the ISO-treated 
group of cells compared with those in the control group of cells (p<0.05).
Conclusion: ISO affected the proliferation of colorectal cancer (CRC) cells via cell cycle pathways. It also 
altered apoptosis gene expression. These results demonstrated that ISO can be a therapeutic agent for CRC 
treatment; however, more studies are needed to investigate its mechanism of actions.
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Introduction
Cancer is a serious health problem worldwide, particularly with rising life expectancy and chang-
ing environmental conditions as well as lifestyle. Moreover, cancer causes genetic alterations 
following failure of homeostatic mechanisms [1]. A large number of changes in gene expres-
sion leading to unregulated control of cell proliferation may result in tumor formation. An 
unregulated cell growth can metastasize and cause significant morbidity and mortality [2]. Thus, 
altered gene expression, particularly of oncogenes and tumor suppressor genes, plays a key role 
in carcinogenesis [3].
Colon cancer originates either from the colon or rectum. Colorectal cancers (CRCs) are the 
most common cancers after lung and breast cancers in women and after lung and prostate 
cancers in men. CRC is the more prevalent form of lower gastrointestinal cancer, and about 75% 
of CRC cases are associated with environmental factors and nutrition. The remaining 25% cases 
have a hereditary CRC association among family members [4]. CRC, with more than a million of 
new cases per year, has few treatment options especially for advanced and metastatic patients.
The cell cycle is defined as experimentally determined intervals, wherein the cells are prepared 
and the genomes are copied equally between the two daughter cells. There are four consecutive 
phases in cell division: G1 phase, during which cells accumulate mass and metabolites necessary 
for DNA replication; S phase, when DNA replicates; G2, a gap phase in which accuracy of DNA 
replication controls; and M phase, in which DNA splicing is successfully completed [5].
Investigation of the Anticancer Mechanism of Isoorientin Isolated 
from Eremurus Spectabilis Leaves via Cell Cycle Pathways in HT-29 
Human Colorectal Adenocarcinoma Cells
Gulsah Gundogdu1 , Yavuz Dodurga2 , Levent Elmas2 , Seymanur Yilmaz Tasci1 , Esen Sezen Karaoglan3 
In eukaryotes, cell cycle continuity depends on 
the sequential activation of the cyclin-dependent 
kinase (CDK) involved in cyclin-dependent acti-
vation [6]. The CDKs are cyclically linked to cell 
cycle continuity enzymes, and these complexes 
are activated. Cyclin D1 (CCND1) overexpres-
sion occurs as a result of gene amplification or 
disorder of growth factors in many types of can-
cer [7].
Apoptosis, which is also known as type 1 pro-
grammed cell death, shows nuclear fragmenta-
tion, chromatin condensation, and generation of 
apoptotic bodies. Apoptosis is mainly regulated 
by extrinsic and intrinsic pathways, which are 
known as death receptor and mitochondria-
mediated pathways, respectively. Both of these 
pathways depend on the activation of caspases 
[8]. Activation of apoptotic pathways is a novel 
mechanism for preventing the development and 
progression of cancer [9].
While most dietary constituents can enhance 
cancer risk, evidence-based studies have report-
ed that there is a negative correlation between 
the routine consumption of any nutrients (food 
and vegetables) and the development of certain 
cancer types. Nowadays, natural compounds 
have garnered great interest because of their 
potential effects on cancer cells; because they 
are thought to be naturally safe, chemopreven-
tive, and chemotherapeutic; and because they 
decrease the mutagenicity of cells [10]. Phyto-
chemicals, which are known as the nonnutritive 
part of a plant-based diet, exhibit substantial 
antimutagenic and anticarcinogenic features. 
The natural populations of Eremurus, which are 
classified into 50 different species, are found in 
different territories such as dry and stony grazed 
hillsides, particularly in Asia and the Middle East. 
Eremurus spectabilis is found in the east side of 
Turkey and is widely distributed. The leaves of 
E. spectabilis are accepted as a vegetable and 
consumed as a meal. Moreover, E. spectabilis has 
been traditionally used for treating some condi-
tions such as hemorrhoids and diabetics and also 
used as antihypertensive and antidysuria agent 
[11]. One of the active components of E. spec-
tabilis is isoorientin (ISO), which has antiprolif-
erative and antinociceptive effects.
Isoorientin is a C-glycosyl flavone; it is called 
3’,4’,5,7-tetrahydroxy-6-C-glucopyranosyl fla-
vone and abbreviated as ISO. It can be extracted 
from different plant species, such as Phyllostachys 
pubescens, Patrinia, Fagopyrum esculentum, Erem-
urus spectabilis, and Drosophyllum lusitanicum 
(Figure 1) [12].
Isoorientin has been reported to have many 
pharmacological activities. Studies performed 
with mice have shown that ISO has antinoci-
ceptive and anti-inflammatory activities [13]. 
Additionally, ISO levels significantly increased in 
apoptotic neurotoxicity induced by 6-hydroxy-
dopamine [14] and reduced the proliferation 
of HepG2 cells [15]. However, in HT-29 human 
colorectal adenocarcinoma cells, the effects of 
ISO-induced apoptosis and anticancer effects 
are not known.
There is increasing evidence that dietary plant 
extracts, particularly from fruits, grains, and 
herbs, play a protective role against colon can-
cer. The chemopreventive properties of these 
compounds include inhibition of cell prolifera-
tion, induction of apoptosis, and scavenging of 
free radicals [16].
The main goal of this study was to investigate 
the potential antiproliferative properties of 
ISO including cell viability, apoptosis, and cell 
cycle-related gene expressions in HT-29 human 
colorectal adenocarcinoma cell line in vitro.
Materials and Methods
This article contains only in vitro cell culture 
study. Therefore, this study does not require the 
Ethics Committee approval and information on 
informed consent.
Reagents and Solutions 
Roswell Park Memorial Institute (RPMI)-1640 
medium with L-glutamine (Gibco, USA), fetal 
bovine serum (FBS) (Gibco, USA), penicillin/
streptomycin (Gibco, USA), phosphate buffered 
saline (Gibco, USA), Trizol reagent (Invitrogen, 
USA), cell proliferation 2,3-bis (2-methoxy-4-ni-
tro-5-sulfophenyl)-2H-tetrazolium-5-carboxani-
lide (XTT) kit (Biological Industries, USA), and 
cDNA synthesis kit (Roche, Germany) were 
used. ISO as an authentic sample was isolated in 
pure form from E. spectabilis.
Cell Culture
In the current study, experiments were per-
formed on human colorectal adenocarcinoma 
cell line HT-29 (ATCC, USA). HT-29 human 
colorectal adenocarcinoma cells were cultured 
in the RPMI-1640 medium containing 2 mM L-
glutamine, 10% FBS, penicillin (20 units/mL), and 
streptomycin (20 μg/mL) at 37 °C with 5% CO2 
and 95% saturated humidity. ISO was dissolved 
in dimethyl sulfoxide (DMSO). The concentra-
tions of ISO ranging from 7.81 µM to 1 mM 
were applied to HT-29 cells for 72 h, where time 
and dose were the dependent variables.
XTT Proliferation Assay
The cytotoxic effect of ISO in HT-29 cells and 
the concentration of ISO that decreased the cell 
viability by 50% (IC50) were determined using 
trypan blue dye exclusion test and XTT assay 
based on the kit protocol. Briefly, HT-29 cells 
were cultured in 96-well plates at a concentra-
tion of 103 and incubated for 24 h (at 37 °C and 
5% CO2) without ISO. After 24 h of incubation, 
the cells were exposed with ISO concentrations 
as mentioned earlier and incubated for 24, 48, 
and 72 h. For the XTT assay, a reaction solution 
for one plate (96 wells) was prepared by adding 
0.1 mL activation solution to 5 mL XTT reagent. 
Then, 50 μL of the reaction mixture was applied 
to the wells and the plate was incubated in an Figure 1. Chemical structure of  isoorientin.
Eurasian J Med 2018; 50(3): 168-172 Gundogdu et al. Anticancer Mechanism of  Isoorientin in HT-29 cell line • 169
incubator for 2–5 h. Formation of formazan 
crystals was spectrophotometrically measured 
at 450 nm (reference wavelength, 630 nm). The 
percentage of viable cells was quantified using 
the following formula:
Viability (%)=Absorbance(dose well)/Absorbance(control 
well)×100
Isolation of RNA, cDNA Synthesis, and Real-
time polymerase chain reaction (RT-PCR)
HT-29 cells were seeded on a six-well plate at a 
concentration of 3×105 cells/well. After a 24-h 
incubation, the IC50 dose of ISO was applied to 
each well excluding the control well. Total RNA 
was isolated according to the Trizol reagent 
protocol. cDNA synthesis was conducted us-
ing Transcriptor First Strand cDNA Synthesis 
kit  (Roche, Germany) as per the manufacturer’s 
instructions. CCND1, CDK6, p21, p53, Caspase-3 
(CASP-3), Caspase-8 (CASP-8, Caspase-9 (CASP-
9),  BCL-2, Ataxia Telangiectasia Mutated (ATM), 
Ataxia Telangiectasia and Rad-3 Related (ATR) , 
BAX, Checkpoint kinase 1-2 (CHEK1, CHEK2) 
and Excision repair cross-complementing 1 
(ERCC1) gene expression analyses were per-
formed using the StepOnePlus quantitative RT-
PCR system (Applied-Biosystems, USA) with 
respect to SYBR Green (Thermo-Scientific, 
USA) method. The RT-PCR analysis was per-
formed using specific primers for the gene. To 
identify gene expressions, the results of the se-
lected gene’s expressions were normalized to 
the beta-actin housekeeping gene.
Statistical Analysis
The analyses of RT-PCR results were performed 
using computer program according to ∆∆CT. 
The groups were compared using Volcano plot 
analyses from RT2 ProfilesTM PCR Array Data 
Analysis with Student t test. A p value of <0.05 
value was considered significant.
Results
XTT Results
The cytotoxic effect of ISO was determined in 
HT-29 cells using XTT assay. Various concentra-
tions (7.81–1000 µM) were used to determine 
the cytotoxic effect of ISO on HT-29 human 
colon cancer cells as shown in the Figure 2. In 
this study, IC50 value of ISO was detected to 
be 125 µM at the 48th h in HT-29 cells using 
XTT assay because no significant result was ob-
served on 24- and 72-h incubations. As seen in 
the Figure 2, DMSO did not show any cytotoxic 
effect on HT-29 human colorectal adenocarci-
noma cells.
RT-PCR Results
Control and IS-induced cells were observed in 
terms of gene expression analysis using RT-PCR 
after total RNA isolation; cDNA synthesis was 
performed using the Transcriptor First Strand 
cDNA Synthesis kit.
Effects of ISO on Cell Cycle-associated Gene 
Proteins 
RT-PCR analysis in the present study demon-
strated that ISO-treated HT-29 cells significantly 
decreased CCND1 and CDK6 expressions with 
respect to the control group cells (p<0.05). 
Furthermore, both p21 and p53 expressions 
were significantly increased in ISO-treated HT-
29 cells compared with those in control group 
cells (p<0.05; Table 1).
Effects of ISO on ATM and ATR Kinases
In our study, while the ATM- and Rad3-related 
(ATR) pathway was activated, ataxia-telangiecta-
sia (ATM) expression was significantly decreased 
(p<0.05; Table 1).
Effects of ISO on Apoptosis-related Genes 
and Proteins
In our study, the PCR analysis demonstrated 
that the expression of antiapoptotic gene Bcl-2 
was significantly lowered in ISO-treated HT-29 
cells compared with that in control group cells 
(p<0.05; Table 1).
Effects of ISO on Caspase-3, and -8 Activities
We determined that ISO has an effect on prote-
ase activities of CASP-3 and CASP-8. There was a 
significant increase in CASP-3 and CASP-8 activa-
tion in ISO-treated HT-29 cells compared with 
that in control group cells (p<0.05; Table 1).
Effects of ISO on Excision repair cross-com-
plementing 1 gene (ERCC1)
In the present study, ERCC1 gene expression 
was reduced in ISO-treated HT-29 cells com-
pared with that in control group cells (Table 1).
Effects of ISO on CHK1 and CHK2
In our study, expressions of CHK1 and CHK2 
were reduced in ISO-treated HT-29 cells com-
pared with those in control group cells (Table 1).
Figure 2. Effects of  ISO on the viability of  HT-29 cells. Isoorientin induced cells at different 
concentrations and time intervals and XTT assay results.
Table 1. Difference in the mRNA expression 
of genes related to beta-actin mRNA expres-
sion was determined using real-time poly-
merase chain reaction in HT-29 cells (p<0.05)

















CCND1: cyclin D1; CDK6: cyclin-dependent 
kinase 6; CASP-3: caspase-3; CASP-8: caspase-8; 
CASP-9: caspase-9; CHEK1: checkpoint kinase 1; 
CHEK2: checkpoint kinase 2; ERCC1: excision repair 
cross-complementing 1; ATM: ataxia telengiectasia 
mutated; ATR: ataxia telengiectasia and rad-3 related.
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Discussion
Natural compounds are novel therapeutic 
agents because of being safe and having a lower 
risk of mutagenicity in normal cells [10]. ISO is 
a common flavonoid found in human diet and 
has been isolated from many plant species [13]. 
Several studies have reported a pharmacologic 
effect of ISO on cancer cells [17].
Isoorientin exerts cytotoxic effects on HT-29 
human colorectal adenocarcinoma cells in a 
both time- and dose-dependent manner. This 
conclusion is based on XTT assay result and it 
was detected that IC50 value of ISO was 125 
µM at the 48th h on HT-29 human colorectal 
adenocarcinoma cells.  In this study, we demon-
strated for the first time the effects of ISO caus-
ing decreased cell viability and proliferation of 
HT-29 human colorectal adenocarcinoma cells. 
ISO also showed similar effects on cell viability 
and proliferation in different cancer cells such 
as MCF-7, the human breast adenocarcinoma 
cells [18], and HepG2, the human hepatocellular 
carcinoma cells [13]. Various studies have dem-
onstrated that apoptotic and cell cycle arrest 
mechanisms are important targets for cancer 
therapeutic strategy [9, 13]. These studies de-
termined the molecular mechanism of ISO and 
its therapeutic activity on HT-29 human colorec-
tal adenocarcinoma cells. In addition, the effects 
of ISO on cell cycle control genes and apoptosis 
were studied.
Recently, apoptosis has garnered a lot of interest 
in oncogenic research. The lifetime of healthy 
and cancerous cells in alive systems is mainly af-
fected by the rate of apoptosis. Apoptosis is a 
different cell death pathway that diverges from 
necrotic cell death and is assumed to be an op-
timal way of cell destruction. Thus, apoptosis 
which is the main target in cancer treatment can 
be modulated by the chemopreventive agents 
[19]. Treatment with such agents can lead to the 
arrest of the cell cycle, thereby causing cessa-
tion of cancerous cell growth and proliferation, 
and may also affect the malign transition. It was 
claimed that tumor growth is related with nor-
mal control mechanisms of cell cycle and caused 
by unprogrammed cells  [20]. In fact, apoptosis 
involves both physiologic and pathologic process 
and it functions as a crucial mechanism for tissue 
homeostasis.
In the present study, we detected the underly-
ing molecular mechanisms of effects of ISO on 
HT-29 human colorectal adenocarcinoma cells 
by evaluating the mRNA expression change of 
genes related to programmed cell death and 
cell cycle arrest. Yuan et al. [13] showed that in 
HepG2 cancer cells, ISO stimulates mitochon-
dria-mediated apoptosis in human hepatoblas-
toma cancer cells and induces apoptosis with the 
dysfunction of mitochondria and inhibits PI3K/
Akt signaling pathway.
Cell cycle transitions are mediated by cyclins 
and CDK regulatory proteins in the cell. The 
CCND1 protein is a major regulator in the cell 
cycle’s G1-S checkpoint, and it has an impor-
tant role in cell cycle arrest, tumor suppressor 
inhibition, or oncogene activation because it is 
related to CDK4 and CDK6 [21]. The folding 
of CCND1/CDK6 or CCND1/CDK4 complexes 
causes inhibition of pRB pathway and activation 
of transcriptional E2F [22]. Oncogenic functions 
and roles of CCND1 in numerous cancer types 
have been determined. Studies on different can-
cer cell lines have shown that overexpression or 
amplification of CCND1 cause tumor cell growth 
[23]. RT-PCR demonstrated that CCND1 and 
CDK6 expressions were significantly reduced in 
HT-29 human colorectal adenocarcinoma cells 
exposed to ISO compared with those in the 
control group cells. Many studies on different 
cancers have indicated that the overexpression 
or amplification of CCND1 cause tumor cell 
growth.
The tumor suppressor protein and transcription 
factor p53 play a key role in the response of nor-
mal mammalian cells to DNA damage and other 
stresses [24, 25]. Two prominent functions of 
p53 to date have been identified: implementa-
tion of growth arrest and execution of apoptotic 
cell death [25]. The p53 protein shows its effects 
on apoptosis by inducing transcription of apop-
tosis-related genes and binding apoptosis-relat-
ed target genes. In our study, the IC50 dose of 
ISO significantly increased in mRNA expression 
of p53 in HT-29 human colorectal adenocarci-
noma cells. Furthermore, mRNA expression 
of p21 was increased in ISO-treated colorectal 
adenocarcinoma cells compared with that in the 
control group cells. With respect to apoptosis- 
and DNA repair-related genes, there was no sig-
nificant expression change in ISO-treated cells. 
These results indicated that ISO has potential 
impacts on cell cycle control in human colorec-
tal adenocarcinoma cells by downregulating 
CCND1 and CDK6. The effect of ISO on cell 
cycle of human colorectal adenocarcinoma cells 
has been shown for the first time in our study.
We studied activated CASP-3 for exploring the 
mechanism of ISO-induced apoptosis in HT-29 
cells. CASP-3 is one of the most important medi-
ators of caspases involved in apoptosis, which is 
found in the cytosol as a zymogen under normal 
circumstances. CASP-3 is either exactly or rela-
tively responsible for the proteolytic cleavage 
of some substrates such as poly (ADP-ribose) 
polymerase, called as the death substrate, dur-
ing the activation of apoptosis [8]. The apoptotic 
pathways are divided into two main pathways. 
CASP-3 activation can affect both intrinsic and 
extrinsic pathways of apoptosis [8]. In addition, 
mitochondria can cause caspase-independent 
apoptosis by releasing endonuclease G, death-
modulating flavoprotein, inhibitor of apoptosis 
protein, and Omi protein [26]. Therefore, ISO-
induced apoptosis is caspase dependent, and 
ISO significantly increases expression levels of 
CASP-3 and CASP-8 in colorectal adenocarci-
noma cells compared with those in the control 
group cells.
Bax is a type of protein that shares homology 
with Bcl-2. Bax is similar to Bcl-2 in several highly 
conserved regions. The Bcl-2 proteins play a role 
in the regulation of apoptosis, causing promo-
tion or suppression of cell death. Cell death is 
promoted by the overexpression of Bax. Bax 
forms homodimers that can cause heterodimer-
ization with other Bcl-2-related proteins. Bcl-2 
genes were first identified in a translocation 
point (14:18) of human B follicular lymphoma.
 
Bcl-2 overexpression induces cell survival in 
spite of the wide range of apoptosis-inducing 
factors such as chemotherapeutic agents and 
radiation [27]. In our study, ISO decreased the 
expression of Bcl-2 in ISO-induced HT-29 cells 
in accordance with the controls. This result sug-
gest that ISO can induce apoptosis by disrupting 
the cell cycle.
ATM and ATR kinases, which are members of the 
phosphatidylinositol-3-kinase-like kinase family, 
are the most upstream DNA damage-related 
kinases [26]. Many proteins are phosphorylated 
at the Ser/Thr-Glu sites and at additional sites in 
an ATM- or ATR-dependent manner in response 
to DNA damage. Both ATM and ATR are activat-
ed at the activation of CHK1 and CHK2 protein 
kinases when the second wave of phosphoryla-
tion occurs [28]. In our study, ISO affected ATM, 
ATR, CHK1, and CHK2 expressions. While the 
ATR pathway was actiavted, ATM, CHK1, and 
CHK2 expressions were decreased in HT-29 
human colorectal adenocarcinoma cell line. It 
suggested that ISO exerts effects on cell cycle 
control.
ERCC1 is a member of nuclear excision repair 
genes, and it encodes a protein that works with 
other members of repairing complex to provide 
genomic integrity through the repair of con-
structional aberrations and chemical nucleotide 
differences [29]. The DNA damage repair func-
tion of ERCC1 is considered to affect the tumor 
behavior. The role of ERCC1 in cancer regarding 
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cancer genesis, disease progression, and clinical 
management is becoming increasingly explicit. 
ERCC1 expression level is predictive of cell sur-
vival. This can be secondary to the lowered ac-
cumulation of genomic differences due to the 
repair of DNA damage [30]. In the present 
study, ISO decreased the expression of ERCC1 
gene. Thus, low ERCC1 expression means poor 
survival of cells. Hence, ISO shortened the life 
span of HT-29 adenocarcinoma cells.
The present study has some limitations. Financial 
limitations and lack of equipment prevented the 
evaluation of cell viability and protein expression 
analyses, such as Western blotting. The lack of fi-
nancial support also prevented researchers from 
confirming the apoptotic effect of ISO using fur-
ther assessments, such as terminal deoxynucleoti-
dyl transferase dUTP nick end-labeling assay.
In conclusion, numerous researches exploring 
new anticancer agents and biomarker molecules 
considered beneficial for cancer treatment should 
be focused specifically on the molecular–cellular 
mechanisms such as inducing programmed cell 
death, DNA damage, and cell cycle arrest. Ac-
cording to our results, ISO inhibits the viability 
and proliferation of colorectal adenocarcinoma 
cells affecting cell cycle arrest mechanisms. We 
explained for the first time the molecular mecha-
nisms of action of ISO in HT-29 human colorec-
tal adenocarcinoma cells. Thus, ISO is a potential 
agent for treatment of human colorectal adeno-
carcinoma. More in vitro and in vivo studies should 
be conducted to determine the optimum safe 
dose and effects of ISO.
Ethics Committee Approval: N/A
Informed Consent: N/A
Peer-review: Externally peer-reviewed. 
Author Contributions: Concept – G.G.; Design – 
G.G., Y.D. Supervision -  G.G., Y.D.; Materials – E.S.K.;
Data Collection and/or Processing – G.G., L.E., Y.D.;
Analysis and/or Interpretation – G.G., Y.D., L.E.,; Litera-
ture Search – G.G., S.Y.T.; Writing Manuscript – G.G.,
Ş.Y.T.; Critical Review – G.G., Y.D.
Acknowledgements: The authors thank Dr. Koksal 
Gundogdu, for his contributions to Literature Search 
and the manuscript writing phase.
Conflict of Interest: Authors have no conflicts of in-
terest to declare.
Financial Disclosure: The authors declared that this 
study has received no financial support.
References
1. Hann D, Baker F, Denniston M, et al. The influ-
ence of social support on depressive symptoms 
in cancer patients: age and gender differences. J 
Psychosom Res 2002; 52: 279-83. [CrossRef]
2. Lahiry L, Saha B, Chakraborty J, et al. Theaflavins tar-
get Fas/caspase-8 and Akt/pBad pathways to induce 
apoptosis in p53-mutated human breast cancer cells. 
Carcinogenesis 2010; 31: 259-68. [CrossRef]
3. Planchard D, Loriot Y, Goubar A, Commo F, So-
ria JC. Differential expression of biomarkers in 
men and women. Semin Oncol 2009; 36: 553-
65. [CrossRef]
4. Migliore L, Migheli F, Spisni R, Coppedé F. Ge-
netics, cytogenetics, and epigenetics of colorec-
tal cancer. J Biomed Biotechnol 2011; 2011: 
792362. [CrossRef]
5. Sherr CJ. A New Cell-Cycle Target in Cancer -
Inhibiting Cyclin D-Dependent Kinases 4 and 6. 
N Engl J Med 2016; 375: 1920-3. [CrossRef]
6. Pan MH, Chen WJ, Lin-Shiau SY, Ho CT, Lin JK. 
Tangeretin induces cell-cycle G1 arrest through 
inhibiting cyclin-dependent kinases 2 and 4 activi-
ties as well as elevating Cdk inhibitors p21 and 
p27 in human colorectal carcinoma cells. Carci-
nogenesis 2002; 23: 1677-84. [CrossRef]
7. Chen XL, Ren KH, He HW, Shao RG. Involve-
ment of PI3K/AKT/GSK3beta pathway in tetran-
drine-induced G1 arrest and apoptosis. Cancer 
Biol Ther 2008; 7: 1073-8. [CrossRef]
8. Soldatenkov VA, Smulson M. Poly(ADP-ribose) 
polymerase in DNA damage-response pathway: 
implications for radiation oncology. Int J Cancer 
2000; 90: 59-67. 
9. Ghobrial IM, Witzig TE, Adjei AA. Targeting 
apoptosis pathways in cancer therapy. CA Can-
cer J Clin 2005; 55: 178-94. [CrossRef]
10. Fabregat I, Roncero C, Fernández M. Survival 
and apoptosis: a dysregulated balance in liver 
cancer. Liver Int 2007; 27: 155-62. [CrossRef]
11. Taskin T, Bitis L, Birteksöz S. Antioxidant and an-
timicrobial activities of different extracts from 
Eremurus spectabilis leaves. Spatula DD-Peer 
Reviewed J Complement Med Drug Discovery 
2012; 2: 213-7. [CrossRef]
12. Yuan L, Wang Y, Wang J, Xiao H, Liu X. Additive 
effect of zinc oxide nanoparticles and isoorientin 
on apoptosis in human hepatoma cell line. Toxi-
col Lett 2014; 225: 294-304. [CrossRef]
13. Yuan L, Wang J, Xiao H, Xiao C, Wang Y, Liu
X. Isoorientin induces apoptosis through mito-
chondrial dysfunction and inhibition of PI3K/Akt 
signaling pathway in HepG2 cancer cells. Toxicol 
Appl Pharmacol 2012; 265: 83-92. [CrossRef]
14. Conforti F, Rigano D, Menichini F, Loizzo MR, Sena-
tore F. Protection against neurodegenerative dis-
eases of Iris pseudopumila extracts and their con-
stituents. Fitoterapia 2009; 80: 62-7. [CrossRef]
15. Pacifico S, Scognamiglio M, D’Abrosca B, et al. 
Spectroscopic characterization and antiprolifera-
tive activity on HepG2 human hepatoblastoma 
cells of flavonoid C-glycosides from Petrorhagia 
velutina. J Nat Prod 2010; 73: 1973-8. [CrossRef]
16. Vadde R, Radhakrishnan S, Reddivari L, Vanamala 
JK. Triphala Extract Suppresses Proliferation and
Induces Apoptosis in Human Colon Cancer
Stem Cells via Suppressing c-Myc/Cyclin D1 and
Elevation of Bax/Bcl-2 Ratio. Biomed Res Int
2015; 2015: 649263. [CrossRef]
17. Kupeli E, Aslan M, Gurbuz I, Yesilada E. Evaluation 
of in vivo biological activity profile of isoorientin.
Z Naturforsch C 2004; 59: 787-90. [CrossRef]
18. Czemplik M, Mierziak J, Szopa J, Kulma A. Fla-
vonoid C-glucosides Derived from Flax Straw
Extracts Reduce Human Breast Cancer Cell
Growth In vitro and Induce Apoptosis. Front
Pharmacol 2016; 7: 282. [CrossRef]
19. Lepley DM, Li B, Birt DF, Pelling JC. The chemo-
preventive flavonoid apigenin induces G2/M ar-
rest in keratinocytes. Carcinogenesis 1996; 17:
2367-75. [CrossRef]
20. Hall PA, Coates PJ, Ansari B, Hopwood D. Regu-
lation of cell number in the mammalian gastroin-
testinal tract: the importance of apoptosis. J Cell
Sci 1994; 107: 3569-77.
21. Sherr CJ, Beach D, Shapiro GI. Targeting CDK4
and CDK6: From Discovery to Therapy. Cancer
Discov 2016; 6: 353-67. [CrossRef]
22. Molenaar JJ, Ebus ME, Koster J, et al. Cyclin D1
and CDK4 activity contribute to the undifferen-
tiated phenotype in neuroblastoma. Cancer Res
2008; 68: 2599-609. [CrossRef]
23. Musgrove EA, Caldon CE, Barraclough J, Stone A,
Sutherland RL. Cyclin D as a therapeutic target in can-
cer. Nat Rev Cancer 2011; 11: 558-72. [CrossRef]
24. Kastan MB, Zhan Q, el-Deiry WS, Carrier F,
Jacks T, Walsh WV, et al. A mammalian cell cycle
checkpoint pathway utilizing p53 and GADD45
is defective in ataxia-telangiectasia. Cell 1992; 71: 
587-97. [CrossRef]
25. Kastan MB, Canman CE, Leonard CJ. P53, cell
cycle control and apoptosis: implications for can-
cer. Cancer Metastasis Rev; 14: 3-15. [CrossRef]
26. Lempiainen H, Halazonetis TD. Emerging com-
mon themes in regulation of PIKKs and PI3Ks.
EMBO J 2009; 28: 3067-73. [CrossRef]
27. Hasnan J, Yusof MI, Damitri TD, Faridah AR,
Adenan AS, Norbaini TH. Relationship between
apoptotic markers (Bax and Bcl-2) and biochem-
ical markers in type 2 diabetes mellitus. Singa-
pore Med J 2010; 51: 50-5. 
28. Liu Q, Guntuku S, Cui XS, et al. Chk1 is an essen-
tial kinase that is regulated by Atr and required
for the G(2)/M DNA damage checkpoint. Genes 
Dev 2000; 14: 1448-59.
29. Simon GR, Sharma S, Cantor A, Smith P, Bepler
G. ERCC1 expression is a predictor of survival in 
resected patients with non-small cell lung cancer. 
Chest 2005; 127: 978-83. [CrossRef]
30. Shirota Y, Stoehlmacher J, Brabender J, et al.
ERCC1 and thymidylate synthase mRNA levels
predict survival for colorectal cancer patients re-
ceiving combination oxaliplatin and fluorouracil
chemotherapy. J Clin Oncol 2001; 19: 4298-304. 
[CrossRef]
172 • Gundogdu et al. Anticancer Mechanism of  Isoorientin in HT-29 cell line Eurasian J Med 2018; 50(3): 168-172
